Companies › Gilead Sciences, Inc.

Gilead Sciences, Inc.

Company Pharma & Medical Devices

Gilead Sciences, Inc. is listed as a company in Pharma & Medical Devices. It has filed 5 comment letters on 5 proposed federal rules between 2022 and 2026, most often with the Centers for Medicare & Medicaid Services. Of those rules, 1 rule became final.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
5
Rules commented on
5
First letter
2022-03-31
Latest letter
2026-09-08
Agencies most often
Centers for Medicare & Medicaid Services (3); Health and Human Services Department (1); Securities and Exchange Commission (1)

Activity by year

20221
20264

Letters

2026

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-08 · filed as “Gilead Sciences”

Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard

CMS-2026-2081Health and Human Services Department · filed 2026-07-17 · filed as “Gilead Sciences”

Global Benchmark for Efficient Drug Pricing (GLOBE) Model

CMS-2025-1889Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25 · filed as “Gilead Sciences”

Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

CMS-2025-1888Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25 · filed as “Gilead Sciences”

2022

Share Repurchase Disclosure Modernization

S7-21-21Securities and Exchange Commission · filed 2022-03-31 Final rule 2023